We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.06%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$355M
AUM Growth
-$58.3M
Cap. Flow
-$49.6M
Cap. Flow %
-13.96%
Top 10 Hldgs %
19.68%
Holding
1,105
New
222
Increased
181
Reduced
330
Closed
90

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$24.9M
2
RACE icon
Ferrari
RACE
+$19.1M
3
CNH
CNH Industrial
CNH
+$12.3M
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$8.23M
5
UBS icon
UBS Group
UBS
+$5.09M

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.09%
2 Technology 16.07%
3 Consumer Discretionary 9.4%
4 Healthcare 9.16%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMBK icon
651
SmartFinancial
SMBK
$883M
$22.9K 0.01%
895
+557
+165% +$14.7K
IJJ icon
652
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.5B
$22.7K 0.01%
207
+20
+11% +$2.16K
RXI icon
653
iShares Global Consumer Discretionary ETF
RXI
$244M
$22.7K 0.01%
145
+13
+10% +$2.09K
TFIN icon
654
Triumph Financial Inc
TFIN
$1.52B
$22.5K 0.01%
+239
New +$23.5K
IJS icon
655
iShares S&P Small-Cap 600 Value ETF
IJS
$7.97B
$22.1K 0.01%
216
+22
+11% +$2.24K
JQC icon
656
Nuveen Credit Strategies Income Fund
JQC
$689M
$21.7K 0.01%
3,507
-4,700
-57% -$29.3K
EW icon
657
Edwards Lifesciences
EW
$51.5B
$21.5K 0.01%
183
-370
-67% -$41.5K
BLBD icon
658
Blue Bird Corp
BLBD
$1.95B
$21.4K 0.01%
1,139
-552
-33% -$10.1K
ILMN icon
659
Illumina
ILMN
$34.6B
$21.3K 0.01%
63
-5
-7% -$1.69K
ITRI icon
660
Itron
ITRI
$4.03B
$21.1K 0.01%
401
-406
-50% -$22.7K
HBNC icon
661
Horizon Bancorp
HBNC
$1B
$21K 0.01%
+1,126
New +$23.3K
LBAI
662
DELISTED
Lakeland Bancorp Inc
LBAI
$20.5K 0.01%
1,226
+750
+158% +$13.9K
XLC icon
663
State Street Communication Services Select Sector SPDR ETF
XLC
$22.9B
$20K 0.01%
291
+29
+11% +$2.04K
DOCU
664
DocuSign
DOCU
$13.2B
$19.2K 0.01%
179
BDX icon
665
Becton Dickinson
BDX
$49.5B
$19.2K 0.01%
74
-1,494
-95% -$385K
SLV icon
666
iShares Silver Trust
SLV
$30.7B
$18.3K 0.01%
799
-4,000
-83% -$88.9K
NVG icon
667
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.45B
$18.2K 0.01%
1,231
-3,258
-73% -$51.2K
TGT icon
668
Target
TGT
$70.3B
$17.2K ﹤0.01%
+81
New +$17.5K
FUBO icon
669
FuboTV Inc
FUBO
$320M
$15.9K ﹤0.01%
202
-30
-13% -$3.5K
TWTR
670
DELISTED
Twitter, Inc.
TWTR
$14.4K ﹤0.01%
+371
New +$13.6K
DB icon
671
Deutsche Bank
DB
$72.1B
$13.9K ﹤0.01%
1,088
-42,537
-98% -$566K
SCPL
672
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$13.8K ﹤0.01%
1,070
BAX icon
673
Baxter International
BAX
$12.2B
$12K ﹤0.01%
155
-16
-9% -$1.34K
TVRD
674
Tvardi Therapeutics
TVRD
$23.1M
$10.6K ﹤0.01%
24
MJ icon
675
Amplify Alternative Harvest ETF
MJ
$110M
$10.4K ﹤0.01%
83

Similar funds

Exane Derivatives's Q1 2022 Portfolio in Review

As of Q1 2022, Exane Derivatives held 1,105 positions worth $355M, down 14% from $413M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Exane Derivatives withdrew a net $49.6M in Q1 2022, closing 90 positions and reducing 330 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $8.23M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Exane Derivatives opened a new position in Visa worth $4.62M.

  • Exane Derivatives's largest Q1 2022 buy was Visa: 20,811 shares worth $4.62M.
  • Exane Derivatives added most to iShares MSCI China ETF in Q1 2022, an estimated $5.54M increase.
  • Exane Derivatives's biggest Q1 2022 reduction was Stellantis, cutting an estimated $24.9M.
  • Exane Derivatives fully exited iShares S&P 500 Value ETF in Q1 2022, selling an estimated $8.23M.
  • Exane Derivatives's ten largest holdings make up 20% of its $355M portfolio in Q1 2022.
  • Exane Derivatives opened 222 new positions and closed 90 in Q1 2022.
  • Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $355M.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.